These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 17364689)

  • 1. L-asparaginase: a promising chemotherapeutic agent.
    Verma N; Kumar K; Kaur G; Anand S
    Crit Rev Biotechnol; 2007; 27(1):45-62. PubMed ID: 17364689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marine microbial L-asparaginase: Biochemistry, molecular approaches and applications in tumor therapy and in food industry.
    Izadpanah Qeshmi F; Homaei A; Fernandes P; Javadpour S
    Microbiol Res; 2018 Mar; 208():99-112. PubMed ID: 29551216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial L-asparaginase: purification, characterization and applications.
    Muneer F; Siddique MH; Azeem F; Rasul I; Muzammil S; Zubair M; Afzal M; Nadeem H
    Arch Microbiol; 2020 Jul; 202(5):967-981. PubMed ID: 32052094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning and characterization of Halomonas elongata L-asparaginase, a promising chemotherapeutic agent.
    Ghasemi A; Asad S; Kabiri M; Dabirmanesh B
    Appl Microbiol Biotechnol; 2017 Oct; 101(19):7227-7238. PubMed ID: 28801829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of L-asparaginase in childhood ALL.
    Müller HJ; Boos J
    Crit Rev Oncol Hematol; 1998 Aug; 28(2):97-113. PubMed ID: 9768345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular expression of l-asparaginase gene from Nocardiopsis alba NIOT-VKMA08 in Escherichia coli: A prospective recombinant enzyme for leukaemia chemotherapy.
    Meena B; Anburajan L; Vinithkumar NV; Shridhar D; Raghavan RV; Dharani G; Kirubagaran R
    Gene; 2016 Sep; 590(2):220-6. PubMed ID: 27155523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEG-asparaginase.
    Fu CH; Sakamoto KM
    Expert Opin Pharmacother; 2007 Aug; 8(12):1977-84. PubMed ID: 17696798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circumventing the side effects of L-asparaginase.
    Fonseca MHG; Fiúza TDS; Morais SB; Souza TACB; Trevizani R
    Biomed Pharmacother; 2021 Jul; 139():111616. PubMed ID: 33932739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments in L-asparaginase discovery and its potential as anticancer agent.
    Shrivastava A; Khan AA; Khurshid M; Kalam MA; Jain SK; Singhal PK
    Crit Rev Oncol Hematol; 2016 Apr; 100():1-10. PubMed ID: 25630663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia.
    Narta UK; Kanwar SS; Azmi W
    Crit Rev Oncol Hematol; 2007 Mar; 61(3):208-21. PubMed ID: 17011787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells.
    Chan WK; Lorenzi PL; Anishkin A; Purwaha P; Rogers DM; Sukharev S; Rempe SB; Weinstein JN
    Blood; 2014 Jun; 123(23):3596-606. PubMed ID: 24659632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial l-asparaginases for cancer therapy: Current knowledge and future perspectives.
    Ghasemian A; Al-Marzoqi AH; Al-Abodi HR; Alghanimi YK; Kadhum SA; Shokouhi Mostafavi SK; Fattahi A
    J Cell Physiol; 2019 Nov; 234(11):19271-19279. PubMed ID: 30993718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent research progress on microbial L-asparaginases.
    Zuo S; Zhang T; Jiang B; Mu W
    Appl Microbiol Biotechnol; 2015 Feb; 99(3):1069-79. PubMed ID: 25492420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bacterial recombinant L-asparaginases: properties, structure and anti-proliferative activity].
    Sokolov NN; Eldarov MA; Pokrovskaya MV; Aleksandrova SS; Abakumova OY; Podobed OV; Melik-Nubarov NS; Kudryashova EV; Grishin DV; Archakov AI
    Biomed Khim; 2015; 61(3):312-24. PubMed ID: 26215408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endophytic Fungi as a Promising Source of Anticancer L-Asparaginase: A Review.
    Parashiva J; Nuthan BR; Rakshith D; Satish S
    Curr Microbiol; 2023 Jul; 80(9):282. PubMed ID: 37450223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a novel asparaginase from soil metagenomic libraries generated from forest soil.
    Arjun JK; Aneesh BP; Kavitha T; Harikrishnan K
    Biotechnol Lett; 2018 Feb; 40(2):343-348. PubMed ID: 29127643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive review on microbial l-asparaginase: Bioprocessing, characterization, and industrial applications.
    Chand S; Mahajan RV; Prasad JP; Sahoo DK; Mihooliya KN; Dhar MS; Sharma G
    Biotechnol Appl Biochem; 2020 Jul; 67(4):619-647. PubMed ID: 31954377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monolith and coating enzymatic microreactors of L-asparaginase: kinetics study by MCE-LIF for potential application in acute lymphoblastic leukemia (ALL) treatment.
    Qiao J; Qi L; Mu X; Chen Y
    Analyst; 2011 May; 136(10):2077-83. PubMed ID: 21461410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plant asparaginase-based asparagine biosensor for leukemia.
    Kumar K; Kataria M; Verma N
    Artif Cells Nanomed Biotechnol; 2013 Jun; 41(3):184-8. PubMed ID: 22991930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of L-asparaginase in acute lymphoblastic leukemia: recommendations of the Polish Adult Leukemia Group.
    Piatkowska-Jakubas B; Krawczyk-Kuliś M; Giebel S; Adamczyk-Cioch M; Czyz A; Lech Marańda E; Paluszewska M; Pałynyczko G; Piszcz J; Hołowiecki J;
    Pol Arch Med Wewn; 2008 Nov; 118(11):664-9. PubMed ID: 19140571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.